Close

Tactical Resources Announces TSXV Listing and CSE Delisting Aug 29, 2023 05:00PM
Tactical Resources Provides Corporate Update on Flagship Peak Project Property Aug 28, 2023 05:00PM
Tactical Resources Refiles Q3 Financial Statements and MD&A Aug 24, 2023 07:12PM
Tactical Resources Provides Top Highlights of 2022 Dec 20, 2022 08:30AM
Tactical Reports Successful Initial Peak Project Metallurgical Results Oct 24, 2022 08:30AM


Sep 30, 2022 08:30AM Tactical Resources Appoints Director with Global Mining Experience
Sep 28, 2022 08:30AM Tactical Resources Completes Geophysics Program at the Lac Ducharme REE Project
Sep 22, 2022 08:30AM Tactical Resources Advances Peak REE Project
Sep 9, 2022 08:30AM Tactical Resources Advances Preliminary Economic Assessment Plans at Peak Project, Texas
Aug 23, 2022 08:30AM Tactical Resources Project Activity Update
Aug 11, 2022 08:30AM Tactical Resources Hires Project Manager for Texas REE Project
Aug 3, 2022 08:30AM Tactical Engages Metallurgical Expert
Jul 28, 2022 08:30AM Tactical Resources Appoints Accomplished Metallurgical Specialist
Jul 20, 2022 08:30AM Tactical Resources Engages Metallurgical Firm to Advance REE Extraction and Process Development
Jun 23, 2022 08:30AM Tactical Resources Initiates Independent NI 43-101 Technical Report on Texas Project
Jun 13, 2022 08:30AM Tactical Resources Announces DTC Eligibility for U.S. Trading
Jun 7, 2022 08:30AM Tactical Resources Provides Corporate Update
Apr 20, 2022 08:30AM Tactical Resources Introduces Texas REE Project
Apr 7, 2022 08:30AM Tactical Resources Foresees Rare Earth Sector Growth
Mar 31, 2022 08:30AM Tactical Resources Introduces Board of Directors
Mar 24, 2022 08:30AM Tactical Resources Introduces Canadian Exploration Assets
Mar 16, 2022 08:30AM Tactical Resources CEO Message
Jan 20, 2022 08:00AM ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
Jan 10, 2022 08:00AM ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer
Jan 7, 2022 07:01AM Regeneron (REGN), Ultragenyx (RARE) Collaborate to Commercialize Evkeeza (evinacumab) Outside the United States
Apr 5, 2021 08:00AM n-Lorem Foundation Partners with Ultragenyx to Bolster Development of Personalized Medicines for Patients with Ultra-Rare Diseases
Jul 2, 2018 02:41AM Dr. Deborah Dunsire named new President and CEO of Lundbeck
Jan 23, 2018 09:23AM Pre-Open Movers 01/23: (RGSE) (CNET) (NFLX) Higher; (GPRO) (ADMS) (TWTR) Lower (more...)
Feb 14, 2017 03:41PM JANA Partners Enters Aetna (AET), Bristol-Myers Squibb (BMY), Lamb Weston (LW), Salesforce (CRM) (more...) - 13F
Nov 14, 2016 07:49AM JANA Partners Enters Kate Spade (KATE), Select Medical (SEM), Twitter (TWTR) (more...)